Notably, these NAFLD mouse models revealed increased levels of nuclear receptor subfamily 4 group A member 1 (Nr4a1), which repressed Bnip3 (Zhou et al., 2017). Here, NR4A1 is linked to metabolic dysfunction-associated steatotic liver disease.